Nuvasive

Visual Financials
Company Name: NuVasive Inc
Ticker Symbol: NUVA
CIK Number: 0001142596
WWW Address: http://www.nuvasive.com
CEO: Mr. Gregory T. Lucier
No. of Employees: 1,500
Common Issue Type: CS
Business Description:NuVasive, Inc, is a medical device company that designs, develops and markets products for the surgical treatment of spine disorders and general back related pains.

 
Industry Information: HEALTH SERVICES - Medical Instruments & Supplies [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 49.6 Up 0.45 49.59 49.61 49.14 49.66 48.69 82794
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 2,542.5 51.3 0.00 1.63 0.00 30.9 0.0 81.68 - 44.62
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close49.16$
PE Ratio - LTM30.9
Market Capitalisation2,542.5mil
Latest Shares Outstanding51.3mil
Earnings pS (EPS)1.63$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee541,853$
Effective Tax Rate0.0%
Float45.5mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue0.50%
Research & Devlopment (R&D) as % of Revenue0.00%
Gross Profit Margin73.9%
EBITDA Margin22.7%
Pre-Tax Profit Margin0.0%
Assets Turnover64.1%
Return on Assets (ROA)5.2%
Return on Equity (ROE)11.1%
Return on Capital Invested (ROCI)8.9%
Current Ratio3.5
Leverage Ratio (Assets/Equity)2.1
Interest Cover3.0
Total Debt/Equity (Gearing Ratio)0.73
LT Debt/Total Capital42.0%
Working Capital pS7.77$
Cash pS0.00$
Book-Value pS14.87$
Tangible Book-Value pS-0.44$
Cash Flow pS3.50$
Free Cash Flow pS1.47$
KEY FIGURES (LTM): Price info
Price/Book Ratio3.30
Price/Tangible Book Ratio0.00
Price/Cash Flow14.1
Price/Free Cash Flow33.4
P/E as % of Industry Group1,456.0%
P/E as % of Sector Segment1,173.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---1.11438,467610,775
4 Weeks54.5546.7252.20-5.1-9694,14814,577,113
13 Weeks56.3446.7247.534.24647,85542,110,584
26 Weeks63.3844.6255.95-11.5-17724,72290,590,327
52 Weeks81.6844.6272.20-31.4-45845,509213,068,337
YTD63.3844.62--19.2-20788,45677,268,746
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
49.6249.5351.8153.3154.820.000.00
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue0.110.40.11
Income0.921.0
Dividend0.0
Capital Spending0.07NA0.16
R&D8.11NA-3.66
Normalized Inc.0.00NA-12.06
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %5.25.214.8
Earnings %-11.4-11.40.0
EPS %0.00.00.0
EPS $0.000.001.80
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio24.30
Current Ratio3.5
Quick Ratio (Acid Test)1.7
Liquidity Ratio (Cash)0.93
Receivables Turnover5.6
Average Collection Period64
Working Capital/Equity50.1
Working Capital pS7.77
Cash-Flow pS3.24
Free Cash-Flow pS1.20
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio2.98
Financial Leverage Ratio (Assets/Equity)0.7
Debt Ratio35.6
Total Debt/Equity (Gearing Ratio)0.73
LT Debt/Equity0.73
LT Debt/Capital Invested49.6
LT Debt/Total Liabilities100.0
Interest Cover3.0
Interest/Capital Invested2.57
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio1.54
Current P/E Ratio - LTM30.90
Enterprise Value (EV)/EBITDA13.77
Enterprise Value (EV)/Free Cash Flow51.12
Dividend Yield0.0
Price/Tangible Book Ratio - LTM0.00
Price/Book Ratio - LTM3.30
Price/Cash Flow Ratio14.1
Price/Free Cash Flow Ratio - LTM33.4
Price/Sales Ratio0.00
P/E Ratio (1 month ago) - LTM322.1
P/E Ratio (26 weeks ago) - LTM0.0
P/E Ratio (52 weeks ago) - LTM0.0
5-Y High P/E Ratio108.9
5-Y Low P/E Ratio28.0
5-Y Average P/E Ratio0.0
Current P/E Ratio as % of 5-Y Average P/E-5
P/E as % of Industry Group1,456.0
P/E as % of Sector Segment1,173.0
Current 12 Month Normalized P/E Ratio - LTM61.8
PER SHARE FIGURES
LT Debt pS12.89
Current Liabilities pS3.55
Tangible Book Value pS - LTM-0.44
Book Value pS - LTM14.87
Capital Invested pS26.89
Cash pS - LTM0.00
Cash Flow pS - LTM3.50
Free Cash Flow pS - LTM1.47
Earnings pS (EPS)1.63
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin6.46
Free Cash Flow Margin 5YEAR AVG5.06
Net Profit Margin0.1
Net Profit Margin - 5YEAR AVRG.0.0
Equity Productivity1.29
Return on Equity (ROE)0.1
Return on Equity (ROE) - 5YEAR AVRG.0.1
Capital Invested Productivity0.75
Return on Capital Invested (ROCI)0.0
Return on Capital Invested (ROCI) - 5YEAR AVRG.0.0
Assets Productivity0.60
Return on Assets (ROA)0.1
Return on Assets (ROA) - 5YEAR AVRG.0.0
Gross Profit Margin73.9
Gross Profit Margin - 5YEAR AVRG.0.7
EBITDA Margin - LTM22.7
EBIT Margin - LTM10.9
Pre-Tax Profit Margin0.1
Pre-Tax Profit Margin - 5YEAR AVRG.0.1
Effective Tax Rate2.0
Effective Tax Rate - 5YEAR AVRG.-7.0
EFFICIENCY RATIOS
Cash Conversion Cycle3,029,464
Revenue per Employee541,853
Net Income per Employee43,687
Average Collection Period3,029,464
Receivables Turnover5.6
Day's Inventory Turnover Ratio
Inventory Turnover1.2
Inventory/Sales24.0
Accounts Payble/Sales0.42
Assets/Revenue1.67
Net Working Capital Turnover2.58
Fixed Assets Turnover0.95
Total Assets Turnover0.6
Revenue per $ Cash14.14
Revenue per $ Plant4.78
Revenue per $ Common Equity1.29
Revenue per $ Capital Invested0.75
Selling, General & Adm/tive (SG&A) as % of Revenue52.4
SG&A Expense as % of Revenue - 5YEAR AVRG.1.0
Research & Devlopment (R&D) as % of Revenue4.9
R&D Expense as % of Revenue - 5YEAR AVRG.4.9

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.